On November 21, 2024, The Beigam Trust filed a Schedule 13D with the SEC, disclosing its acquisition of a significant stake in Exela Technologies. The trust now holds 3,220,140 shares, representing 11.6% of the company's common stock.The acquisition involved the exchange of 60,375 shares of Series A Preferred Stock for 846,307 common shares. Additionally, The Beigam Trust received distributions of 2,000,000 shares from HOF 2, LLC and 373,548 shares from Adesi 234, LLC, with no purchase price or payment involved.This filing highlights The Beigam Trust's strategic position in Exela Technologies, potentially influencing future corporate decisions and shareholder dynamics.

On November 21, 2024, The Beigam Trust filed a Schedule 13D with the SEC, disclosing its acquisition of a significant stake in Exela Technologies. The trust now holds 3,220,140 shares, representing 11.6% of the company's common stock.The acquisition involved the exchange of 60,375 shares of Series A Preferred Stock for 846,307 common shares. Additionally, The Beigam Trust received distributions of 2,000,000 shares from HOF 2, LLC and 373,548 shares from Adesi 234, LLC, with no purchase price or payment involved.This filing highlights The Beigam Trust's strategic position in Exela Technologies, potentially influencing future corporate decisions and shareholder dynamics.